Exicure (XCUR) Receivables - Net (2018 - 2020)
Exicure's (XCUR) quarterly Receivables - Net came in at $11000.0 in Q4 2020, down 31.25% YoY from $16000.0 in Q1 2020, and down 81.36% on a QoQ basis from $59000.0 in Q3 2020.
Exicure (XCUR) Receivables - Net (2018 - 2020) Analysis & Trends
Exicure (XCUR) has 3 years of Receivables - Net data on file, last reported at $11000.0 in Q4 2020.
- Quarterly Receivables - Net fell 31.25% year-over-year to $11000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $11000.0 (down 31.25% YoY) and the FY2020 annual result came in at $11000.0, down 31.25% from the prior year.
- Receivables - Net declined to $11000.0 in Q4 2020, from $59000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $59000.0 in Q3 2020 to a low of $3000.0 in Q1 2019.
- A 3-year average of $26375.0 and a median of $21500.0 in 2018 frame the typical range for Receivables - Net.
- The widest YoY moves for Receivables - Net: up 800.0% in 2020, down 31.25% in 2020.
- Tracing XCUR's Receivables - Net over 3 years: stood at $52000.0 in 2018, then tumbled by 69.23% to $16000.0 in 2019, then plunged by 31.25% to $11000.0 in 2020.
- The last three Receivables - Net figures came in at $11000.0 (Q4 2020), $59000.0 (Q3 2020), and $21000.0 (Q2 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - |
| 10 | Exicure | 8.09 Mn | 8.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 11,000.00 |
| Dec 31, 2020 | 11,000.00 |
| Sep 30, 2020 | 59,000.00 |
| Sep 30, 2020 | 59,000.00 |
| Jun 30, 2020 | 21,000.00 |
| Jun 30, 2020 | 21,000.00 |
| Mar 31, 2020 | 27,000.00 |
| Mar 31, 2020 | 27,000.00 |
| Dec 31, 2019 | 16,000.00 |
| Dec 31, 2019 | 16,000.00 |
| Mar 31, 2019 | 3,000.00 |
| Mar 31, 2019 | 3,000.00 |
| Sep 30, 2018 | 52,000.00 |
| Sep 30, 2018 | 52,000.00 |
| Jun 30, 2018 | 22,000.00 |
| Jun 30, 2018 | 22,000.00 |